References
- Hovakimyan A, Baglivo E, Cunningham ET Jr. Fuchs Uveitis Syndrome in the developing world. Int Ophthalmol Clin. 2010;50(2):145–153. doi:https://doi.org/10.1097/IIO.0b013e3181d2cd4c.
- Yalçındağ FN, Özdal PC, Özyazgan Y, Batıoğlu F, Tugal-Tutkun I; BUST Study Group. Demographic and clinical characteristics of Uveitis in Turkey: the first national registry report. Ocul Immunol Inflamm. 2018;26(1):17–26. doi:https://doi.org/10.1080/09273948.2016.1196714.
- Sun Y, Ji Y. A literature review on Fuchs uveitis syndrome: an update. Surv Ophthalmol. 2019 Oct 14:pii: S0039-6257(19)30282–6. doi:https://doi.org/10.1016/j.survophthal.2019.10.003.
- La Hey E, de Jong PT, Kijlstra A. Fuchs’ heterochromic cyclitis: review of the literature on the pathogenetic mechanisms. Br J Ophthalmol. 1994;78:307–312. doi:https://doi.org/10.1136/bjo.78.4.307.
- Quentin CD, Reiber H. Fuchs heterochromic cyclitis: rubellavirus antibodies and genome in aqueous humor. Am J Ophthalmol. 2004;138:46–54. doi:https://doi.org/10.1016/j.ajo.2004.02.055.
- Barequet IS, Li Q, Wang Y, O’Brien TP, Hooks JJ, Stark WJ. Herpes simplex virus DNA identification from aqueous fluid in Fuchs heterochromic iridocyclitis. Am J Ophthalmol. 2000;129:672–673. doi:https://doi.org/10.1016/S0002-9394(00)00409-8.
- Schwab IR. The epidemiologic association of Fuchs’ heterochromie iridocyclitis and ocular toxoplasmosis. Am J Ophthalmol. 1991;111:356–362. doi:https://doi.org/10.1016/S0002-9394(14)72322-0.
- Chan NS, Chee SP, Caspers LB. Clinical features of CMV-associated anterior Uveitis. Ocul Immunol Inflamm. 2018;26:107–115. doi:https://doi.org/10.1080/09273948.2017.1394471.
- Norrsell K, Sjödell L. Fuchs’ heterochromic uveitis: a longitudinal clinical study. Acta Ophthalmol. 2008;86(1):58–64. doi:https://doi.org/10.1111/j.1600-0420.2007.00990.x.
- Kreps EO, Derveaux T, De Keyser F, Kestelyn P. Fuchs’ Uveitis syndrome: no longer a syndrome? Ocul Immunol Inflamm. 2016;24(3):348–357. doi:https://doi.org/10.3109/09273948.2015.1005239.
- Jones NP. Fuchs’ heterochromic uveitis: a reappraisal of the clinical spectrum. Eye. 1991;5:649–661. doi:https://doi.org/10.1038/eye.1991.121.
- Tugal-Tutkun I, Güney-Tefekli E, Kamaci-Duman F, Corum I. A cross-sectional and longitudinal study of Fuchs uveitis syndrome in Turkish patients. Am J Ophthalmol. 2009;148(4):510–515. doi:https://doi.org/10.1016/j.ajo.2009.04.007.
- Mohamed Q, Zamir E. Update on Fuchs’ uveitis syndrome. Curr Opin Ophthalmol. 2005;16(6):356–363. doi:https://doi.org/10.1097/01.icu.0000187056.29563.8d.
- Bouchenaki N, Herbort CP. Fluorescein angiographic findings and clinical features in Fuchs’ uveitis. Int Ophthalmol. 2010;30:511–519. doi:https://doi.org/10.1007/s10792-010-9366-z.
- Zarei M, Darabeigi S, Mehrpour M, Roohipoor R, Ghassemi H, Ebrahimiadib N. Fuchs’ Uveitis in Iranian patients: a review of 89 eyes. Ocul Immunol Inflamm. 2018 Jul 30:1–9. doi:https://doi.org/10.1080/09273948.2018.1500612.
- Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005;140:509–516.
- Yang P, Fang W, Jin H, Li B, Chen X, Kijlstra A. Clinical features of Chinese patients with Fuchs’ syndrome. Ophthalmology. 2006;113(3):473–480. doi:https://doi.org/10.1016/j.ophtha.2005.10.028.
- Chee SP, Jap A. Presumed fuchs heterochromic iridocyclitis and Posner-Schlossman syndrome: comparison of cytomegalovirus-positive and negative eyes. Am J Ophthalmol. 2008;146(6):883‐9. doi:https://doi.org/10.1016/j.ajo.2008.09.001.
- Agarwal A, Aggarwal K, Kumar A, Gupta V. Anterior Uveitis: Differential Diagnosis. In: Gupta V, Nguyen QD, LeHoang P, Agarwal A, editors. The Uveitis Atlas. Springer; 2020. p. 53–61.
- Tandon M, Malhotra PP, Gupta V, Gupta A, Sharma A. Spectrum of Fuchs uveitic syndrome in a North Indian population. Ocul Immunol Inflamm. 2012;20(6):429–433. doi:https://doi.org/10.3109/09273948.2012.723113.
- Liesegang TJ. Clinical features and prognosis in Fuchs’ uveitis syndrome. Arch Ophthalmol. 1982;100:1622–1626. doi:https://doi.org/10.1001/archopht.1982.01030040600009.
- Bouchenaki N, Herbort CP. Fuchs’ Uveitis: failure to associate vitritis and disc hyperfluorescence with the disease is the major factor for misdiagnosis and diagnostic delay. Middle East Afr J Ophthalmol. 2009;16(4):239–244. doi:https://doi.org/10.4103/0974-9233.58424.
- Norrsell K, Holmér AK, Jacobson H. Aqueous flare in patients with monocular iris atrophy and uveitis. A laser flare and iris angiography study. Acta Ophthalmol Scand. 1998;76(4):405–412. doi:https://doi.org/10.1034/j.1600-0420.1998.760404.x.
- Berger BB, Tessler HH, Kottow MH. Anterior segment ischemia in Fuchs’heterochromic cyclitis. Arch Ophthalmol. 1980;98(3):499–501. doi:https://doi.org/10.1001/archopht.1980.01020030495012.
- Aziz S, Arya B, Westcott M, Pavesio C. An investigation of the disc hyperfluorescence in Fuchs uveitis syndrome using optical coherence tomography imaging. Ocul Immunol Inflamm. 2015;23(2):152–156. doi:https://doi.org/10.3109/09273948.2014.890229.
- Jad A, Céline T, Bahram B, Phuc L, Nathalie C. Fuchs’ heterochromic cyclitis: a post-infectious manifestation of ocular toxoplasmosis? Int Ophthalmol. 2013;33(2):189–194. doi:https://doi.org/10.1007/s10792-012-9649-7.
- Toledo de Abreu M, Jr BR, PS H. Fuchs’ heterochromic cyclitis and ocular toxoplasmosis. Am J Ophthalmol. 1982;93(6):739–744. doi:https://doi.org/10.1016/0002-9394(82)90470-6.